Companies: 10,795·Total market cap: $144.5T
Aligos Therapeutics, Inc.

Aligos Therapeutics, Inc.

ALGSNASDAQHealthcare● Active
$5.21
+$0.25(+5.04%)
Market Cap$32240637
P/E Ratio
52W High$13.689
52W Low$4.8
Overview

Aligos Therapeutics, Inc. (ALGS) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ALGS · as of Mar 5, 2026

Latest filing snapshot

82
+12+17.14%vs prior year

Aligos Therapeutics, Inc. (ALGS) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
82
Change (1Y)
+12
Growth % (1Y)
+17.14%
Revenue / Employee
$26.7K
Net Income / Employee
$-295.0K
Market Cap
$31M

ALGS Employee Count

2020 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-0582+12+17.14%
2025-03-1070+4+6.06%
2024-03-1266-17-20.48%
2023-03-0983-10-10.75%
2022-03-1093+19+25.68%
2021-03-2374

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
FibroGen, Inc.
FGEN
FibroGen, Inc.
225
#2
Barinthus Biotherapeutics plc
BRNS
Barinthus Biotherapeutics plc
105
#3
Mersana Therapeutics, Inc.
MRSN
Mersana Therapeutics, Inc.
102
#4
Aligos Therapeutics, Inc.
ALGS
Aligos Therapeutics, Inc.YOU
82
#5
Kezar Life Sciences, Inc.
KZR
Kezar Life Sciences, Inc.
55
#6
CEL-SCI Corporation
CVM
CEL-SCI Corporation
43
#7
INmune Bio, Inc.
INMB
INmune Bio, Inc.
13
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ALGS peer comparison

About ALGS employees

ALGS Employees · Headcount

Aligos Therapeutics, Inc. (ALGS) employee data is sourced from the annual SEC 10-K filing. As of 2025, Aligos Therapeutics, Inc. had 82 full-time employees globally. Full-time employees only. Global consolidated headcount.

Aligos Therapeutics, Inc. employs 82 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $26,659, reflecting the company's operational efficiency.

Aligos Therapeutics, Inc.'s workforce increased by 12 (17.14%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Aligos Therapeutics, Inc.'s revenue per employee of $26,659 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

ALGS Employees · 5 questions

As of the latest SEC 10-K filing (2025), Aligos Therapeutics, Inc. had 82 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Aligos Therapeutics, Inc. employee counthow many employees does Aligos Therapeutics, Inc. haveALGS total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-05